Seeking Alpha

Cubist Pharmaceuticals (CBST -1.3%) slips on a less-than-stellar initiation at Credit Suisse...

Cubist Pharmaceuticals (CBST -1.3%) slips on a less-than-stellar initiation at Credit Suisse with a Neutral rating and a $52 price target. The firm says it expects that positive CXA-201 data in the second half will strengthen confidence in the long-term sustainability of it's antibiotic franchise and be the impetus for global expansion.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)